Riskpilot← Back to searchSign inGet full accessNOSCOMED MEDICAL SUPPLY A/S
A/SActiveCVR 27680461Svanemøllevej 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200344 employees
Revenue 2025
DKK 37,9M
+13% vs 2024
EBITDA margin
27.2%
+187% vs 2024
Equity ratio
40.1%
Financial strength
Net profit 2025
DKK 5,9M
+693% vs 2024
| Revenue | DKK 37,9M | +13% |
| EBITDA | DKK 10,3M | +187% |
| Net profit | DKK 5,9M | +693% |
| Total assets | DKK 59,6M | +1% |
| Equity | DKK 23,9M | +32% |
| Employees | 44 | — |
Legal name
NOSCOMED MEDICAL SUPPLY A/S
CVR number
27680461
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. maj 2003
Share capital
DKK 500.100
Employees
44 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør og af to bestyrelsesmedlemmer i forening med en direktør.
Company purpose
Selskabets formål er at drive virksomhed med investering og handel, herunder handel med medicinsk udstyr og kosmetiske produkter samt, direkte eller indirekte, at drive virksomhed der efter bestyrelsens skøn er forbunden dermed.
Address
Svanemøllevej 11
Phone
+4536306444
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.909 | 8.941 | 8.333 | 9.229 | 7.124 | 11.064 | 15.945 | 23.034 | 25.606 | 31.505 | 31.325 | 35.274 | 33.461 | 37.949 |
| Staff expenses | -6.570 | -6.794 | -7.184 | -7.278 | -6.996 | -8.401 | -10.906 | -14.932 | -15.387 | -20.236 | -30.246 | -32.254 | -29.856 | -27.615 |
| EBITDA | 2.339 | 2.147 | 1.149 | 1.951 | 128 | 2.664 | 5.039 | 8.102 | 10.219 | 11.269 | 1.079 | 3.020 | 3.605 | 10.333 |
| Depreciation & amort. | -562 | -488 | -476 | -296 | -287 | -646 | -753 | -981 | -995 | -897 | -1.055 | -1.323 | -1.542 | -1.813 |
| EBIT | 1.777 | 1.660 | 673 | 1.655 | -159 | 2.017 | 4.286 | 7.121 | 9.225 | 10.371 | 24 | 1.697 | 2.063 | 8.520 |
| Net financials | -178 | -136 | -120 | -95 | -78 | -198 | 132 | 339 | -922 | 107 | 470 | -1.548 | -954 | -792 |
| Profit before tax | 1.599 | 1.524 | 553 | 1.560 | -237 | 1.820 | 4.419 | 7.460 | 8.303 | 10.478 | 494 | 149 | 1.109 | 7.729 |
| Tax | 428 | 405 | 150 | 387 | -12 | 425 | 999 | 1.683 | 1.863 | 2.332 | 174 | 107 | 362 | 1.801 |
| Net profit | 1.171 | 1.118 | 403 | 1.173 | -225 | 1.394 | 3.419 | 5.776 | 6.439 | 8.145 | 321 | 43 | 747 | 5.928 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10.912 | 9.363 | 9.365 | 10.355 | 12.529 | 16.009 | 22.182 | 29.282 | 36.322 | 41.783 | 42.672 | 52.237 | 58.953 | 59.562 |
| Equity | 3.782 | 4.900 | 4.203 | 5.376 | 4.652 | 6.046 | 9.465 | 17.342 | 15.781 | 17.027 | 17.347 | 17.390 | 18.137 | 23.885 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7.130 | 4.462 | 5.162 | 4.979 | 7.877 | 9.957 | 12.615 | 11.864 | 20.501 | 24.583 | 24.977 | 34.393 | 40.134 | 35.177 |
| Total debt | 7.130 | 4.462 | 5.162 | 4.979 | 7.877 | 9.957 | 12.615 | 11.864 | 20.501 | 24.583 | 24.977 | 34.393 | 40.134 | 35.177 |
EBITDA margin
27.2%
This company
15.8%
Market median
+72% vs market
20122025
Equity ratio
40.1%
This company
38.2%
Market median
+5% vs market
20122025
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20122025
Net profit margin
15.6%
This company
8.1%
Market median
+93% vs market
20122025
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
20122025
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CA Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
RA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
TS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
MK Management | Management | 2013 | — | — |
ST Management | Management | 2014 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
KS Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
TP Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2004 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PRO-MEDUC GROUP A/S | Company | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pro-Meduc Holding A/S
NOSCOMED MEDICAL SUPPLY A/S Board members of NOSCOMED MEDICAL SUPPLY A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlotte Alexandra Pedersen | Chief Executive Officer | 0 companies |
| Ronni Aaberg Jansen | Chief Executive Officer | 0 companies |
| Titus Sixten Hinsch Gylvin | Chief Executive Officer | 0 companies |
| Michael Klarskov Jensen | Management | 0 companies |
| Saila Tuulikki Roitto | Management | 0 companies |
| Pernille Mette Ritlov | Chief Executive Officer | 0 companies |
| Klaus Spärck Abel | Chief Executive Officer | 0 companies |
| Tine Pauline Sell Hellmann | Chief Executive Officer | 0 companies |
| Jakob Mohr Christensen | Chief Executive Officer | 0 companies |
| Carsten Hellmann | Chairman | 0 companies |
| Sanne Wall-Gremstrup | Chairman | 0 companies |
| Tina Fruergård Raasteen | Board of Directors | 0 companies |
| Benedicte Francoise Simone Flambard | Board of Directors | 0 companies |
| Steffen Theodor Petersen | Board of Directors | 0 companies |
| Amalie Victoria Sell Hellmann | Board of Directors | 0 companies |
| Jan Kuhlmann Andersen | Board of Directors | 0 companies |